Funded Tech Companies

Avalyn Pharma

Avalyn Pharma, operating out of Seattle, received equity investments through SR One Capital Management, Catalio Capital Management and Piper Heartland.

Company Overview

Contact Information

Company Background Information

Overview

Avalyn is developing inhaled approaches to treat people with severe respiratory disease. Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/27/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Bruce Montgomery

        

Chief Scientific Officer

Mark Surber

        

VP - Finance

Nancy McKinley

        

VP - Operations

Kelly Otto

        

VP - Product Management

Stephen Pham

        

Company Investors

• SR One Capital Management
• Catalio Capital Management
• Piper Heartland
• Pivotal bioVenture Partners
• Wellington Management Company
• Norwest Venture Partners
• Perceptive Xontogeny Venture Fund
• Rock Springs Capital
• F-Prime Capital
• Vida Ventures
• RiverVest Venture Partners
• Novo Holdings
• T. Rowe Price
• Eventide Asset Management
• Surveyor Capital
• TPG Biotech
• Novo Ventures

Browse more funded tech companies:

Avalor | Avametric

Share this article

About Our Venture Capital Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary